Internal Medicine Journal

Papers
(The H4-Index of Internal Medicine Journal is 22. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Non‐alcoholic fatty liver disease: a review of epidemiology, risk factors, diagnosis and management110
How COVID‐19 has pushed us into a medical education revolution74
Tocilizumab therapy in rheumatoid arthritis with interstitial lung disease: a multicentre retrospective study66
Telehealth in cancer care: during and beyond the COVID‐19 pandemic58
Consensus guidelines for the diagnosis and management of invasive aspergillosis, 202149
Risk factors, treatment and outcomes of subacute thyroiditis secondary to COVID‐19: a systematic review43
Health status and healthcare trends of individuals accessing Australian aged care programmes over a decade: the Registry of Senior Australians historical cohort38
Rituximab therapy in interstitial lung disease associated with rheumatoid arthritis38
Consensus guidelines for antifungal prophylaxis in haematological malignancy and haemopoietic stem cell transplantation, 202136
Australian and New Zealand consensus statement on the management of lymphoma, chronic lymphocytic leukaemia and myeloma during the COVID‐19 pandemic35
Patient satisfaction and acceptability with telehealth at specialist medical outpatient clinics during the COVID‐19 pandemic in Australia34
Nursing homes: the titanic of cruise ships – will residential aged care facilities survive the COVID‐19 pandemic?31
Effect of the COVID‐19 induced phase of massive telehealth uptake on end‐user satisfaction28
Idiopathic inflammatory myopathies: a review28
Portopulmonary hypertension: prognosis and management in the current treatment era – results from the REHAP registry28
2004 chronic obstructive pulmonary disease with and without bronchiectasis in Aboriginal Australians: a comparative study27
Machine learning in the prediction of medical inpatient length of stay26
Consensus guidelines for the diagnosis and management of invasive fungal disease due to moulds other than Aspergillus in the haematology/oncology setting, 202125
Immunosuppression as a risk factor for COVID‐19: a meta‐analysis25
Consensus guidelines for optimising antifungal drug delivery and monitoring to avoid toxicity and improve outcomes in patients with haematological malignancy and haemopoietic stem cell transplant reci24
Evaluation of the effect of COVID‐19 pandemic on anxiety severity of physicians working in the internal medicine department of a tertiary care hospital: a cross‐sectional survey24
Quality of care in inflammatory bowel disease: actual health service experiences fall short of the standards23
0.030553817749023